1. Barton RL, Briggs SL, Koppel GA (1991) Monoclonal antibody drug targeting. Drugs News and Perspectives 4: 73–88
2. Bonavida B, Wright SC (1987) Multistage model of NK cell mediated cytotoxicity involving NKCF as soluable cytotoxic mediators. Adv Can Res 49: 169–187
3. Bonavida B, Tsuchitani T, Safrit J, Zighelboim J (1989) Mechanism of target cell lysis by cytotoxic cells, factors, and drugs. In: Tapiero H, Robert J, and Lampidis TJ (eds) Anti cancer drugs. Colloque INSERM. Libbey Eurotext, London, pp 113–128
4. Brunda MJ, Davatelis V (1985) Augmentation of NK cell activity by recombinant IL-2 and recombinant IFNs. In: Herberman R (ed) Mechanisms of cytotoxicity by NK cells. Academic Press, New York, pp 397–407
5. Capel ID, Leach D, Dorrel HM (1983) Vitamin E retards the lipoperoxidation resulting from anticancer drug administration. Anticancer Res 3: 59–62